Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor

Nucleic Acids Research

Volumn 32, Issue 16, 2004, Pages 4758-4767

  Mason, Stephen W ^a   Lawetz, Carol ^a   Gaudette, Yvon ^a   Dô, Florence ^a   Scouten, Erika ^a   Lagacé, Lisette ^a   Simoneau, Bruno ^a   Liuzzi, Michel ^a,b  

^a BOEHRINGER INGELHEIM CANADA LTD   (Canada)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEOPROTEIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; RNA DIRECTED RNA POLYMERASE; STREPTAVIDIN; VIRUS RNA; MESSENGER RNA; RNA DIRECTED DNA POLYMERASE;

ANALYTICAL EQUIPMENT; ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC SCREENING; HEP 2 CELL; HUMAN; HUMAN CELL; ISOTOPE LABELING; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEIC ACID IMMOBILIZATION; POLYADENYLATION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA TRANSCRIPTION; CELL LINE; CHEMISTRY; ENZYMOLOGY; EVALUATION; GENETIC PROCEDURES; GENETIC TRANSCRIPTION; ISOLATION AND PURIFICATION; METABOLISM;

NEWCASTLE DISEASE VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

CELL LINE; GENETIC TECHNIQUES; HUMANS; POLYADENYLATION; RESPIRATORY SYNCYTIAL VIRUSES; REVERSE TRANSCRIPTASE INHIBITORS; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; TRANSCRIPTION, GENETIC;

EID: 4444345610     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkh809     Document Type: Article

References (46)

1. Collins,P.L., Chanock,R.M. and Murphy,B.R. (2001) Respiratory syncytial virus. In Knipe,D.M.H.P.M. (ed.), Fields Virology. Lippincott, Williams & Wilkens, NY, pp. 1443-1485.
2. Hall,C.B., McBride,J.T., Walsh,E.E., Bell,D.M., Gala,C.L., Hildreth,S., Ten Eyck,L.G. and Hall,W.J. (1983) Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N. Engl. J. Med., 308, 1443-1447.
3. Prince,G.A. (2001) An update on respiratory syncytial virus antiviral agents. Expert. Opin. Investig. Drngs, 10, 297-308.
4. Groothuis,J.R. and Nishida,H. (2002) Prevention of respiratory syncytial virus infections in high-risk infants by monoclonal antibody (palivizumab). Pediatr. Int., 44, 235-241.
5. Prince,A.M. and Jacobs,R.F. (2001) Prevention of respiratory syncytial virus infection in high risk infants. J. Ark. Med. Soc., 98, 115-118.
6. Collins,P.L., Hill,M.G., Cristina,J. and Grosfeld,H. (1996) Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc. Natl Acad. Sci. USA, 93, 81-85.
7. Hardy,R.W. and Wertz,G.W. (1998) The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription. J. Virol., 72 520-526.
8. Samal,S.K., Pastey,M.K., McPhillips,T.H. and Mohanty,S.B. (1993) Bovine respiratory syncytial virus nucleocapsid protein expressed in insect cells specifically interacts with the phosphoprotein and the M2 protein. Virology, 193, 470-473.
9. Garcia-Barreno,B., Delgado,T. and Melero,J.A. (1996) Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions. J. Virol., 70, 801-808.
10. Slack,M.S. and Easton,A.J. (1998) Characterization of the interaction of the human respiratory syncytial virus phosphoprotein and nucleocapsid protein using the two-hybrid system. Virus Res., 55 167-176.
11. Mallipeddi,S.K., Lupiani,B. and Samal,S.K. (1996) Mapping the domains on the phosphoprotein of bovine respiratory syncytial virus required for N-P interaction using a two-hybrid system. J. Gen. Virol. 77 (Pt 5), 1019-1023.
12. Krishnamurthy,S. and Samal,S.K. (1998) Identification of regions of bovine respiratory syncytial virus N protein required for binding to P protein and self-assembly. J. Gen. Virol., 79 (Pt 6), 1399-1403.
13. Hengst,U. and Kiefer,P. (2000) Domains of human respiratory syncytial virus P protein essential for homodimerization and for binding to N and NS1 protein. Virus Genes, 20, 221-225.
14. Khattar,S.K., Yunus,A.S., Collins,P.L. and Samal,S.K. (2000) Mutational analysis of the bovine respiratory syncytial virus nucleocapsid protein using a minigenome system: mutations that affect encapsidation, RNA synthesis, and interaction with the phosphoprotein. Virology, 270, 215-228.
15. Khattar,S.K., Yunus,A.S., Collins,P.L. and Samal,S.K. (2001) Deletion and substitution analysis defines regions and residues within the phosphoprotein of bovine respiratory syncytial virus that affect transcription, RNA replication, and interaction with the nucleoprotein. Virology, 285, 253-269.
16. Khattar,S.K., Yunus,A.S. and Samal,S.K. (2001) Mapping the domains on the phosphoprotein of bovine respiratory syncytial virus required for N-P and P-L interactions using a minigenome system. J. Gen. Virol., 82, 775-779.
17. Murray,J., Loney,C., Murphy,L.B., Graham,S. and Yeo,R.P. (2001) Characterization of monoclonal antibodies raised against recombinant respiratory syncytial virus nucleocapsid (N) protein: identification of a region in the carboxy terminus of N involved in the interaction with P protein. Virology, 289, 252-261.
18. Mason,S.W., Aberg,E., Lawetz,C., DeLong,R., Whitehead,P. and Liuzzi,M. (2003) Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity. J. Virol., 77, 10670-10676.
19. Barik,S. (1992) Transcription of human respiratory syncytial virus genome RNA in vitro: requirement of cellular factor(s). J. Virol., 66, 6813-6818.
20. Huang,Y.T., Romito,R.R., De,B.P. and Banerjee,A.K. (1993) Characterization of the in vitro system for the synthesis of mRNA from human respiratory syncytial virus. Virology, 193, 862-867.
21. Herman,R.C. (1989) Synthesis of respiratory syncytial virus RNA in cell-free extracts. J. Gen. Virol., 70 (Pt 3), 755-761.
22. Barik,S. (1993) The structure of the 5′ terminal cap of the respiratory syncytial virus mRNA. J. Gen. Virol., 74 (Pt 3 , 485-490.
23. Mazumder,B. and Barik,S. (1994) Requirement of casein kinase II-mediated phosphorylation for the transcriptional activity of human respiratory syncytial viral phosphoprotein P: transdominant negative phenotype of phosphorylation-defective P mutants. Virology, 205 104-111.
24. Berger,S.L. (1987) Quantifying 32P-labeled and unlabeled nucleic acids. Methods Enzymol., 152, 49-54.
25. Robertson,J.S., Schubert,M. and Lazzarini,R.A. (1981) Polyadenylation sites for influenza virus mRNA. J. Virol., 38 157-163.
26. Zheng,H., Lee,H.A., Palese,P. and Garcia-Sastre,A. (1999) Influenza A virus RNA polymerase has the ability to stutter at the polyadenylation site of a viral RNA template during RNA replication. J. Virol., 73, 5240-5243.
27. Austel,A., Kutter,E., Heider,U., Eberlein,W., Korginger,W., Lillie,C., Diederen,W. and Haarmann,W. (1979) Imidazoisoquinoline-diones and salts thereof. Patent 4,176,184.
28. Hamaguchi,M., Yoshida,T., Nishikawa,K., Naruse,H. and Nagai,Y. (1983) Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology, 128, 105-117.
29. Carlsen,S.R., Peluso,R.W. and Moyer,S.A. (1985) In vitro replication of Sendai virus wild-type and defective interfering particle genome RNAs. J. Virol., 54, 493-500.
30. McKercher,G., Beaulieu,P.L., Lamarre,D., LaPlante,S., Lefebvre,S., Pellerin,C., Thauvette,L. and Kukolj,G. (2004) Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate. Nucleic Acids Res., 32, 422-431.
31. Poon,L.L., Pritlove,D.C., Fodor,E. and Brownlee,G.G. (1999) Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template. J. Virol., 73, 3473-3476.
32. Seong,B.L. and Brownlee,G.G. (1992) A new method for reconstituting influenza polymerase and RNA in vitro: a study of the promoter elements for cRNA and vRNA synthesis in vitro and viral rescue in vivo. Virology, 186, 247-260.
33. Sambrook,J. and Russel,D.W. (2000) Molecular Cloning: A Laboratroy Manual. CSHL Press, Cold Spring Harbor, NY.
34. Hamaguchi,M., Nishikawa,K.. Toyoda,T., Yoshida,T., Hanaichi,T. and Nagai,Y. (1985) Transcriptive complex of Newcastle disease virus. II. Structural and functional assembly associated with the cytoskeletal framework. Virology, 147, 295-308.
35. Chattopadhyay,D. and Banerjee,A.K. (1988) NH2-terminal acidic region of the phosphoprotein of vesicular stomatitis virus can be functionally replaced by tubulin. Proc. Natl Acad. Sci. USA, 85 7977-7981.
36. De,B.P., Lesoon,A. and Banerjee,A.K. (1991) Human parainfluenza virus type 3 transcription in vitro: role of cellular actin in mRNA synthesis. J. Virol., 65, 3268-3275.
37. Moyer,S.A., Baker,S.C. and Lessard,J.L. (1986) Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs. Proc. Natl Acad. Sci. USA, 83, 5405-5409.
38. Burke,E., Mahoney,N.M., Almo,S.C. and Barik,S. (2000) Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA. J. Virol., 74, 669-675.
39. Burke,E., Dupuy,L., Wall,C. and Barik,S. (1998) Role of cellular actin in the gene expression and morphogenesis of human respiratory syncytial virus. Virology, 252, 137-148.
40. Dillon,K.J., Smith,G.C. and Martin,N.M. (2003) A FlashPlate assay for the identification of PARP-1 inhibitors. J. Biomol. Screen. 8, 347-352.
41. Earnshaw,D.L. and Pope,A.J. (2001) FlashPlate scintillation proximity assays for characterization and screening of DNA polymerase, primase, and helicase activities. J. Biomol. Screen., 6, 39-46.
42. Zhang,J.H., Chung,T.D. and Oldenburg,K.R. (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen., 4, 67-73.
43. Crumpacker,C.S. (1992) Mechanism of action of foscarnet against viral polymerases. Am. J. Med., 92, 3S-7S.
44. Robertson,J.S., Schubert,M. and Lazzarini,R.A. (1981) Polyadenylation sites for influenza virus mRNA. J. Virol., 38 157-163.
45. Zheng,H., Lee,H.A., Palese,P. and Garcia-Sastre,A. (1999) Influenza A virus RNA polymerase has the ability to stutter at the polyadenylation site of a viral RNA template during RNA replication. J. Virol., 73, 5240-5243.
46. Zhao,J., Hyman,L. and Moore,C. (1999) Formation of mRNA 3′ ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol. Mol. Biol. Rev., 63 405-445.